Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,200 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Telemedical Interventional Management in Heart Failure II (TIM-HF2), a randomised, controlled trial investigating the impact of telemedicine on unplanned cardiovascular hospitalisations and mortality in heart failure patients: study design and description of the intervention.
Koehler F, Koehler K, Deckwart O, Prescher S, Wegscheider K, Winkler S, Vettorazzi E, Polze A, Stangl K, Hartmann O, Marx A, Neuhaus P, Scherf M, Kirwan BA, Anker SD. Koehler F, et al. Among authors: marx a. Eur J Heart Fail. 2018 Oct;20(10):1485-1493. doi: 10.1002/ejhf.1300. Epub 2018 Sep 19. Eur J Heart Fail. 2018. PMID: 30230666 Free article. Clinical Trial.
Prognostic performance of serial in-hospital measurements of copeptin and multiple novel biomarkers among patients with worsening heart failure: results from the MOLITOR study.
Düngen HD, Tscholl V, Obradovic D, Radenovic S, Matic D, Musial Bright L, Tahirovic E, Marx A, Inkrot S, Hashemi D, Veskovic J, Apostolovic S, von Haehling S, Doehner W, Cvetinovic N, Lainscak M, Pieske B, Edelmann F, Trippel T, Loncar G. Düngen HD, et al. Among authors: marx a. ESC Heart Fail. 2018 Apr;5(2):288-296. doi: 10.1002/ehf2.12231. Epub 2018 Feb 24. ESC Heart Fail. 2018. PMID: 29476612 Free PMC article. Clinical Trial.
A functional variant of the neuropeptide S receptor-1 gene modulates clinical outcomes and healthcare utilization in patients with systolic heart failure: results from the Interdisciplinary Network Heart Failure (INH) Study.
Angermann CE, Kaspar M, Marx A, Kittel-Schneider S, Menhofer D, Störk S, Ertl G, Domschke K, Deckert J, Reif A. Angermann CE, et al. Among authors: marx a. Eur J Heart Fail. 2017 Mar;19(3):314-323. doi: 10.1002/ejhf.706. Epub 2016 Dec 18. Eur J Heart Fail. 2017. PMID: 27990720 Free article.
Prognostic potential of midregional pro-adrenomedullin following decompensation for systolic heart failure: comparison with cardiac natriuretic peptides.
Morbach C, Marx A, Kaspar M, Güder G, Brenner S, Feldmann C, Störk S, Vollert JO, Ertl G, Angermann CE; INH Study Group and the Competence Network Heart Failure. Morbach C, et al. Among authors: marx a. Eur J Heart Fail. 2017 Sep;19(9):1166-1175. doi: 10.1002/ejhf.859. Epub 2017 May 17. Eur J Heart Fail. 2017. PMID: 28516504 Free article.
Should procalcitonin be measured routinely in acute decompensated heart failure?
Loncar G, Tscholl V, Tahirovic E, Sekularac N, Marx A, Obradovic D, Veskovic J, Lainscak M, von Haehling S, Edelmann F, Arandjelovic A, Apostolovic S, Stanojevic D, Pieske B, Trippel T, Dungen HD. Loncar G, et al. Among authors: marx a. Biomark Med. 2015;9(7):651-9. doi: 10.2217/bmm.15.29. Biomark Med. 2015. PMID: 26174839
Frequency and prognostic impact of mid-expiratory flow reduction in stable patients six months after hospitalisation for heart failure with reduced ejection fraction.
Brenner S, Christa M, Berliner D, Deubner N, Ertl G, Held M, Marx A, Angermann CE, Störk S, Rutten FH, Güder G. Brenner S, et al. Among authors: marx a. Int J Cardiol. 2017 Jan 15;227:727-733. doi: 10.1016/j.ijcard.2016.10.071. Epub 2016 Oct 28. Int J Cardiol. 2017. PMID: 27816302 Clinical Trial.
DNA-methylation of the homeodomain transcription factor PITX2 reliably predicts risk of distant disease recurrence in tamoxifen-treated, node-negative breast cancer patients--Technical and clinical validation in a multi-centre setting in collaboration with the European Organisation for Research and Treatment of Cancer (EORTC) PathoBiology group.
Maier S, Nimmrich I, Koenig T, Eppenberger-Castori S, Bohlmann I, Paradiso A, Spyratos F, Thomssen C, Mueller V, Nährig J, Schittulli F, Kates R, Lesche R, Schwope I, Kluth A, Marx A, Martens JW, Foekens JA, Schmitt M, Harbeck N; European Organisation for Research and Treatment of Cancer (EORTC) PathoBiology group. Maier S, et al. Among authors: marx a. Eur J Cancer. 2007 Jul;43(11):1679-86. doi: 10.1016/j.ejca.2007.04.025. Epub 2007 Jun 29. Eur J Cancer. 2007. PMID: 17601725
1,200 results